What forms or injection methods are available for Tezspire treatment in severe asthma patients?

Tezspire is available as a prefilled syringe or autoinjector for subcutaneous injection, typically given once every four weeks under the skin in the thigh, abdomen, or upper arm.

Overview

Severe asthma patients exploring Tezspire may wonder how the treatment is administered. Understanding the available forms helps set realistic expectations for dosing ease and lifestyle compatibility. This article briefly covers:

• The injection method and Tezspire’s delivery devices
• How the treatment works in the body to help manage asthma
• Key safety details and approval status
• Where and how to access Tezspire internationally

Let’s begin by looking at how Tezspire works in the body.

Detailed Information

How it works

Tezspire is a monoclonal antibody that may work by blocking thymic stromal lymphopoietin (TSLP), a key molecule involved in airway inflammation. By targeting this upstream trigger, Tezspire may help reduce asthma attacks regardless of traditional biomarker levels, such as eosinophils.

Clinical applications

According to the external product listing for Tezspire, it is used as an add-on maintenance treatment in adults and adolescents aged 12 and older with severe asthma not controlled by standard therapies. Its use is not limited to one asthma subtype, making it a potential option for a broader group of patients.

Safety and Effectiveness

Safety profile

As noted in the IMOH product summary, common side effects include pharyngitis, arthralgia, rash, and injection site reactions. In rare cases, hypersensitivity reactions may occur. Patients should be monitored for anaphylaxis during and after the injection.

FDA approval and indications

Tezspire is FDA-approved for add-on maintenance treatment of severe asthma in certain adults and adolescents. This supports its use alongside existing treatments under physician supervision.

Access and Availability

How to obtain safely

IsraelPharm offers international access to Tezspire at competitive rates. Visit our website or contact our pharmacy team to review shipping and prescription requirements. Always consult your healthcare provider to determine if Tezspire is appropriate for your treatment plan.

Key Takeaways

• Tezspire is given via subcutaneous injection once every four weeks.
• It is available as a prefilled syringe or an autoinjector for at-home or clinical use.
• It may help reduce inflammation by targeting the TSLP pathway.
• Tezspire is FDA-approved for severe asthma in patients 12 and older.
• International access is possible through licensed pharmacies like IsraelPharm.

FAQ

Can I administer Tezspire at home?

Yes, patients trained in proper injection technique can use the autoinjector or prefilled syringe at home after receiving provider guidance.

How often do I need to take Tezspire?

Tezspire is typically administered once every four weeks as a subcutaneous injection.

Does Tezspire require refrigeration?

Yes, it should be stored in the refrigerator. Allow it to reach room temperature before injection and do not freeze it.

Is Tezspire covered by insurance or government health plans?

Coverage depends on your country and provider. In many locations, it may be covered under specialty asthma care programs. Speak with your insurer or pharmacist.

What does Tezspire cost through IsraelPharm?

Prices may vary. You can check current pricing for Tezspire and shipping details directly on the IsraelPharm website or speak with a team member for personalized assistance.